Metraipolis › archive › dc_0860fea3bcf2

Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer — Europe PMC PMID:41912484

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41912484
DOI
10.1038/s41419-[numero omesso]-0
License (as archived)
solo-consultazione
Archived
2026-11-03T16:40:55.910Z
SHA-256 of the archived text
8da187360b679722a1c3f31d9876bb1481752d837f3a744b306ed2445025b1c8
Stable URL of this page
https://metraipolis.com/documento/dc_0860fea3bcf2

How to cite

Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer — Europe PMC PMID:41912484 — Europe PMC (en), https://europepmc.org/article/MED/41912484 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_0860fea3bcf2 (Metraipolis archive dc_0860fea3bcf2, sha256 8da187360b679722a1c3f31d9876bb1481752d837f3a744b306ed2445025b1c8)
BibTeX
@misc{dc0860fea3bcf2,
  title = {Targeted inhibition of the CREB1-CtIP axis enhances the efficacy of abiraterone combined with radiotherapy in prostate cancer — Europe PMC PMID:41912484},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41912484},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_0860fea3bcf2; sha256 8da187360b679722a1c3f31d9876bb1481752d837f3a744b306ed2445025b1c8},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41912484. Agents can read the archived copy with the MCP tool read_document.